Guggenheim Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,192
Closed -$247K 1835
2025
Q3
$247K Buy
+9,192
New +$219K ﹤0.01% 1451
2022
Q4
Sell
-6,969
Closed -$492K 1984
2022
Q3
$492K Sell
6,969
-1,042
-13% -$89.2K ﹤0.01% 1488
2022
Q2
$568K Sell
8,011
-603
-7% -$38.9K ﹤0.01% 1518
2022
Q1
$688K Sell
8,614
-1,954
-18% -$146K ﹤0.01% 1539
2021
Q4
$965K Sell
10,568
-10,467
-50% -$1.12M 0.01% 1386
2021
Q3
$2.7M Sell
21,035
-612
-3% -$85.6K 0.02% 899
2021
Q2
$3.3M Buy
21,647
+2,271
+12% +$299K 0.02% 840
2021
Q1
$2.04M Buy
+19,376
New +$1.94M 0.01% 1013

Other funds holding STAA

Guggenheim Capital's STAA Position: Q4 2025 in Review

Guggenheim Capital sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 9,192 shares — an estimated $247K sold.

Guggenheim Capital first reported a position in STAA in Q1 2021 and held it in 8 quarters. The position peaked at $3.3M in Q2 2021. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

  • Guggenheim Capital reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
  • Guggenheim Capital sold 9,192 STAAR Surgical shares in Q4 2025, an estimated $247K.
  • Guggenheim Capital first reported a position in STAAR Surgical in Q1 2021 and held it in 8 quarters.
  • Guggenheim Capital's STAAR Surgical position peaked at $3.3M in Q2 2021.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Guggenheim Capital's 13F filing for Q4 2025, filed 17 Feb 2026.